CN107109470B - 用于诊断胃癌的miRNA生物标志物 - Google Patents

用于诊断胃癌的miRNA生物标志物 Download PDF

Info

Publication number
CN107109470B
CN107109470B CN201580054452.0A CN201580054452A CN107109470B CN 107109470 B CN107109470 B CN 107109470B CN 201580054452 A CN201580054452 A CN 201580054452A CN 107109470 B CN107109470 B CN 107109470B
Authority
CN
China
Prior art keywords
mir
mirnas
hsa
gastric cancer
mirna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201580054452.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN107109470A (zh
Inventor
朱兴奋
周砺寒
邹瑞阳
杨启源
苏博欣
朱峰
杨维平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NAT UNIVERSITY HOSPITAL SINGAP
Agency for Science Technology and Research Singapore
National University of Singapore
Original Assignee
NAT UNIVERSITY HOSPITAL SINGAP
Agency for Science Technology and Research Singapore
National University of Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NAT UNIVERSITY HOSPITAL SINGAP, Agency for Science Technology and Research Singapore, National University of Singapore filed Critical NAT UNIVERSITY HOSPITAL SINGAP
Publication of CN107109470A publication Critical patent/CN107109470A/zh
Application granted granted Critical
Publication of CN107109470B publication Critical patent/CN107109470B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
CN201580054452.0A 2014-08-07 2015-08-11 用于诊断胃癌的miRNA生物标志物 Active CN107109470B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG10201404742W 2014-08-07
SG10201404742W 2014-08-07
PCT/SG2015/050256 WO2016022076A1 (en) 2014-08-07 2015-08-11 Microrna biomarker for the diagnosis of gastric cancer

Publications (2)

Publication Number Publication Date
CN107109470A CN107109470A (zh) 2017-08-29
CN107109470B true CN107109470B (zh) 2020-09-15

Family

ID=55264222

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580054452.0A Active CN107109470B (zh) 2014-08-07 2015-08-11 用于诊断胃癌的miRNA生物标志物

Country Status (7)

Country Link
US (1) US10767230B2 (https=)
EP (3) EP4137586B1 (https=)
JP (3) JP6702935B2 (https=)
KR (2) KR102604163B1 (https=)
CN (1) CN107109470B (https=)
SG (2) SG11201700944RA (https=)
WO (1) WO2016022076A1 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4137586B1 (en) * 2014-08-07 2026-04-22 Agency for Science, Technology and Research Microrna biomarker for the diagnosis of gastric cancer
WO2016182511A1 (en) * 2015-05-08 2016-11-17 Agency For Science, Technology And Research Method for diagnosis and prognosis of chronic heart failure
CN106636334B (zh) * 2016-10-09 2020-07-03 山东大学 microRNA标志物组及其在制备检测胃癌淋巴结转移试剂盒中的应用
JP6280997B1 (ja) * 2016-10-31 2018-02-14 株式会社Preferred Networks 疾患の罹患判定装置、疾患の罹患判定方法、疾患の特徴抽出装置及び疾患の特徴抽出方法
CN106755377B (zh) * 2016-12-12 2021-05-25 浙江省中医院 一种胃癌血清学检测鉴定试剂盒及方法
EP3601564A4 (en) * 2017-03-23 2021-03-31 Quadrant Biosciences Inc. PROCESS FOR DIAGNOSING OR MONITORING CONDITIONS CHARACTERIZED BY ABNORMAL TEMPORAL VARIATIONS, PROCESS FOR NORMALIZING EPIGENETIC DATA TO COMPENSATE FOR TEMPORAL VARIATIONS
CL2017002289A1 (es) 2017-09-08 2019-08-16 Univ Pontificia Catolica Chile Método no invasivo de diagnóstico temprano de cáncer gástrico, usando como biomarcador los niveles de metilación de la secuencia de adn del promotor del microrna -335-5p
CN107723366B (zh) * 2017-09-11 2019-10-01 朱伟 一种与贲门癌辅助诊断相关的血清miRNA标志物及其应用
CN107746880B (zh) * 2017-11-01 2018-12-14 健生生物技术有限公司 一种基于RT-qPCR法检测胃癌的试剂盒及其制备方法和应用
CN108611414A (zh) * 2018-04-26 2018-10-02 北京工业大学 新的靶向肿瘤微环境与肺癌干细胞相互作用的miRNA的检测及应用
CN108743617A (zh) * 2018-05-03 2018-11-06 武汉科技大学 miR-15a-5p在提高CAR-T细胞抗肿瘤能力中的应用
CN112534053A (zh) * 2018-06-21 2021-03-19 公立大学法人名古屋市立大学 胃癌生物标志物及其用途
KR102089559B1 (ko) * 2018-08-31 2020-03-16 차의과학대학교 산학협력단 난소의 fsh에 대한 반응성의 진단 또는 예측용 바이오마커 및 이의 용도
TW202018727A (zh) 2018-11-09 2020-05-16 財團法人工業技術研究院 整體式學習預測方法與系統
SG11202106638UA (en) * 2018-12-19 2021-07-29 Agency Science Tech & Res Method of diagnosing gastric cancers using micrornas
WO2020132494A2 (en) * 2018-12-21 2020-06-25 Baylor Research Institute Methods for prognosing, diagnosing, and treating gastric cancer
CN110066870B (zh) * 2019-04-12 2021-12-14 江苏省人民医院（南京医科大学第一附属医院） hsa-miR-382-5p在制备诊断视网膜变性疾病的试剂盒中的应用
CN117683885A (zh) * 2019-04-30 2024-03-12 觅瑞实验室私人有限公司 一种检测胃癌的miRNA标志物组合及试剂盒
EP4008793A4 (en) 2019-08-02 2023-04-12 Kabushiki Kaisha Toshiba ANALYTICAL METHOD AND KIT
KR102288359B1 (ko) * 2019-12-06 2021-08-10 주식회사 레피겐엠디 면역력 감소에 의한 질병의 발병 위험 예측용 다중 유전자 마커 및 이를 이용한 질병의 발병 위험 예측 방법
CN111471764B (zh) * 2019-12-27 2023-09-15 陈锦飞 一种用于筛查或辅助诊断胃癌的生物标志物组合及其试剂盒和应用
JP7511823B2 (ja) * 2020-01-24 2024-07-08 株式会社The IT Lab ｍｉＲＮＡの発現レベルをがんの確定診断の前のスクリーニングの指標として用いるがんの診断を補助する方法
CN111471683B (zh) * 2020-04-15 2021-09-07 湖南省科域生物医药科技有限公司 miR-93-5p作为诊断和治疗胃癌标志物的应用
KR102489708B1 (ko) * 2020-09-14 2023-01-18 서울대학교산학협력단 GDF11 유전자의 발현을 조절하는 PCBP2와 microRNA를 함유하는 조성물
CN112226514B (zh) * 2020-11-23 2021-08-03 苏州京脉生物科技有限公司 用于早期胃癌检测的标志物组合、试剂盒及其应用
CN112941185B (zh) * 2021-03-26 2023-06-23 杭州医学院 miR-29a作为标志物在制备恶性间皮瘤检测试剂盒中的应用
CN113151477B (zh) * 2021-05-08 2022-04-15 武汉大学中南医院 用于检测肠癌的miRNA标记物及其应用
CN113186285B (zh) * 2021-05-10 2022-05-24 深圳市展行生物有限公司 一种辅助诊断胃癌的方法及其使用的miRNA组合
CN113913516B (zh) * 2021-05-26 2023-08-29 东莞市松山湖中心医院(东莞市石龙人民医院、东莞市第三人民医院、东莞市心血管病研究所) hsa_circ_0006470作为靶点在制备miR-27b-3p的调节剂的应用
JP7406059B1 (ja) 2022-10-20 2023-12-27 防衛装備庁長官 急性ストレス評価用データの生成方法
WO2024229279A2 (en) * 2023-05-02 2024-11-07 Dana-Farber Cancer Institute, Inc. Use of circulating microrna profiles for identification of brca1 or brca2 mutations
CN118547069B (zh) * 2024-05-14 2025-08-22 北京热景生物技术股份有限公司 一种基于细胞外囊泡miRNA的胃癌诊断标志物及其应用
WO2025245056A1 (en) * 2024-05-20 2025-11-27 City Of Hope Gastric cancer rna biomarkers and uses thereof
CN119082291A (zh) * 2024-09-24 2024-12-06 中国人民解放军总医院第二医学中心 用于诊断评估心肌衰老的miRNA标志物、试剂盒及其应用
CN119580829A (zh) * 2024-11-25 2025-03-07 苏州大学 一种早期胃癌检测的标志物识别方法及诊断模型构建方法
CN119351558A (zh) * 2024-12-10 2025-01-24 西藏自治区人民政府驻成都办事处医院 一种检测胃癌的标志物、检测试剂盒及药物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102007223A (zh) * 2008-02-28 2011-04-06 俄亥俄州立大学研究基金会 用于胃癌的诊断、预后和治疗的基于微rna的方法和组合物
WO2012010584A1 (en) * 2010-07-20 2012-01-26 Febit Holding Gmbh Complex mirna sets as novel biomarkers for gastric cancer
CN103773761A (zh) * 2014-01-14 2014-05-07 南京医科大学 检测胃癌的血清/血浆微小rna标志物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013245505B2 (en) * 2006-01-05 2016-06-23 The Ohio State University Research Foundation MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
EP2487258B1 (en) * 2006-01-05 2014-10-01 The Ohio State University Research Foundation MicroRNA-based methods for the diagnosis of colon, pancreas and stomach cancer
WO2009147656A1 (en) 2008-06-01 2009-12-10 Rosetta Genomics Ltd. Compositions and methods for prognosis of gastric cancer
CN101988059B (zh) 2009-07-30 2014-04-02 江苏命码生物科技有限公司 胃癌检测标记物及其检测试剂盒和生物芯片
US9939442B2 (en) 2011-09-08 2018-04-10 The Regents Of The University Of California Salivary biomarkers for gastric cancer detection
JP2013085542A (ja) * 2011-10-21 2013-05-13 Sysmex Corp 胃癌の検出方法、胃癌の血液マーカーおよびその使用
GB201317887D0 (en) * 2013-10-09 2013-11-20 Reneuron Ltd Product
CN103937888B (zh) * 2014-04-14 2016-08-17 上海交通大学 鉴别胃癌的血浆microRNA标志物的筛选与应用
EP4137586B1 (en) * 2014-08-07 2026-04-22 Agency for Science, Technology and Research Microrna biomarker for the diagnosis of gastric cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102007223A (zh) * 2008-02-28 2011-04-06 俄亥俄州立大学研究基金会 用于胃癌的诊断、预后和治疗的基于微rna的方法和组合物
WO2012010584A1 (en) * 2010-07-20 2012-01-26 Febit Holding Gmbh Complex mirna sets as novel biomarkers for gastric cancer
CN103773761A (zh) * 2014-01-14 2014-05-07 南京医科大学 检测胃癌的血清/血浆微小rna标志物及其应用

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis;Liu R等;《Eur J Cancer》;20110331;第47卷(第5期);第784-791页 *
A two-microRNA signature as a potential biomarker for early gastric cancer;Zheng G等;《Oncol Lett》;20140331;第7卷(第3期);第679-684页 *
MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin;Liu T等;《Cancer Lett》;20090118;第273卷(第2期);第233-242页 *
Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer;Kim SY等;《J Mol Diagn》;20130625;第15卷(第5期);第661-669页 *
血清miRNA作为胃癌早期诊断标记物的初步研究;国芳等;《胃肠病学》;20140425;第19卷(第4期);第198-202页 *

Also Published As

Publication number Publication date
EP3744859B1 (en) 2025-05-07
EP3177739A1 (en) 2017-06-14
WO2016022076A1 (en) 2016-02-11
JP6702935B2 (ja) 2020-06-03
US10767230B2 (en) 2020-09-08
US20170233822A1 (en) 2017-08-17
EP3744859A2 (en) 2020-12-02
KR20210057079A (ko) 2021-05-20
CN107109470A (zh) 2017-08-29
KR102604163B1 (ko) 2023-11-20
KR20170035932A (ko) 2017-03-31
EP3744859A3 (en) 2021-03-17
JP2017525350A (ja) 2017-09-07
EP4137586A1 (en) 2023-02-22
KR102237960B1 (ko) 2021-04-08
EP3177739A4 (en) 2018-05-02
JP7614735B2 (ja) 2025-01-16
JP2020141684A (ja) 2020-09-10
EP3177739B1 (en) 2019-10-23
JP2022188053A (ja) 2022-12-20
EP4137586B1 (en) 2026-04-22
SG10202011339RA (en) 2020-12-30
SG11201700944RA (en) 2017-03-30
JP7635186B2 (ja) 2025-02-25

Similar Documents

Publication Publication Date Title
CN107109470B (zh) 用于诊断胃癌的miRNA生物标志物
CN107429295B (zh) 通过检测微小RNA(miRNA)的表达水平来确定患乳腺癌的风险的方法
US8765371B2 (en) Method for the in vitro detection and differentiation of pathophysiological conditions
US20120184453A1 (en) Biomarkers for recurrence prediction of colorectal cancer
KR102096498B1 (ko) 대장암 진단 또는 재발 예측을 위한 마이크로RNA-4732-5p 및 이의 용도
US20230227914A1 (en) Biomarkers of oral, pharyngeal and laryngeal cancers
CN108949969B (zh) 长链非编码rna在结直肠癌中的应用
US20180251836A1 (en) Novel mirna biomarkers and use thereof
KR102096499B1 (ko) 대장암 진단 또는 재발 예측을 위한 마이크로rna-3960 및 이의 용도
WO2015127103A1 (en) Methods for treating hepatocellular carcinoma
US9689036B2 (en) miRNA biomarkers for ulcerative colitis
WO2014193522A1 (en) Biomolecular events in cancer revealed by attractor molecular signatures

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20170829

Assignee: Hangzhou miyin Biotechnology Co.,Ltd.

Assignor: Meirui Private Ltd.

Contract record no.: X2022990000090

Denomination of invention: MiRNA biomarkers for the diagnosis of gastric cancer

Granted publication date: 20200915

License type: Common License

Record date: 20220218

EE01 Entry into force of recordation of patent licensing contract